Federated Hermes, Inc. Immuneering Corp Transaction History
Federated Hermes, Inc.
- $43.6 Billion
- Q3 2024
A detailed history of Federated Hermes, Inc. transactions in Immuneering Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 5,135 shares of IMRX stock, worth $8,883. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,135
Previous 4,509
13.88%
Holding current value
$8,883
Previous $5,000
140.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IMRX
# of Institutions
41Shares Held
4.64MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.07MShares$1.85 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD810KShares$1.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$922,7190.0% of portfolio
-
Morgan Stanley New York, NY449KShares$777,3080.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny246KShares$426,0470.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $45.7M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...